Banmeet Anand
Corporate Officer/Principal presso HARPOON THERAPEUTICS, INC.
Posizioni attive di Banmeet Anand
Società | Posizione | Inizio | Fine |
---|---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/07/2022 | - |
Storia della carriera di Banmeet Anand
Precedenti posizioni note di Banmeet Anand
Società | Posizione | Inizio | Fine |
---|---|---|---|
MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Formazione di Banmeet Anand
University of Missouri | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Aziende private | 1 |
---|---|
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Banmeet Anand
- Esperienza